How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology.

Krebs E, Weymann D, Bubela T, Regier DA

Open source

DOI
10.3389/fmed.2025.1563950
Published
2025
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1563950,
  title = {How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology.},
  author = {Krebs E and Weymann D and Bubela T and Regier DA},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1563950},
  url = {https://doi.org/10.3389/fmed.2025.1563950}
}

RIS

TY  - JOUR
TI  - How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology.
AU  - Krebs E
AU  - Weymann D
AU  - Bubela T
AU  - Regier DA
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1563950
UR  - https://doi.org/10.3389/fmed.2025.1563950
ER  - 

APA

E, K., D, W., T, B., & DA, R. (2025). How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1563950

Source records